Update: Respiratory syncytial virus activity - United States, 1998-1999 season

Morbidity and Mortality Weekly Report

Volumn 48, Issue 48, 1999, Pages 1104-1115

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042279841     PISSN: 01492195     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Institute of Medicine. [Appendix N]: Prospects for immunizing against respiratory syncytial virus. In: Institute of Medicine. New vaccine development: establishing priorities. Vol II. Disease importance in developing countries. Washington, DC: National Academy Press, 1986:299-307.
2. Gilchrist S, Török TJ, Gary HE Jr, Alexander JP, Anderson LJ. National surveillance for respiratory syncytial virus, United States, 1985-1990. J Infect Dis 1994;170:986-90.
3. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999;282;15:1440-6.
4. Lowther SA, Shay DK, Holman RC, Clarke MJ, Kaufman SF, Anderson LJ. Bronchiolitis-associated hospitalizations among American Indian and Alaska Native Children. Pediatr Infect Dis J 2000 (in press).
5. Dowell SF, Anderson LJ, Gary HE Jr, et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Pediatr 1996; 174:456-62.
6. Wang EEL, Law BJ, Stephens D, et al. Pediatric Investigators' Collaborative Network on Infections in Canada (PICNIC): prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infections. J Pediatr 1995; 126:212-9.
7. Whimbey E, Couch RB, Englund JA, et al. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin Infect Dis 1995;21:376-9.
8. CDC. Guideline for infection control in health care personnel, 1998. Am J Infect Control 1998; 26:289-354.
9. Committee on Infectious Diseases, Committee on Fetus and Newborn, American Academy of Pediatrics. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. Pediatrics 1998;102:1211-6.